1.
Fridberg G, Amit O, Sherf Y, Perry C, Herishanu Y, Joffe E, Shragai T, Vitkon R, Preis M, Perk S, Sarid N, Barouch SB, Gold R, Glait-Santar C, Avivi I, Ram R. ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study. Haematologica; https://doi.org/10.3324/haematol.2025.288954 [Early view].